Matches in SemOpenAlex for { <https://semopenalex.org/work/W2394880936> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2394880936 abstract "Despite substantial therapeutic advances, the long-term survival rate of patients with high-risk neuroblastoma (NB), a tumor of the peripheral sympathetic nervous system is still dismal. Activating mutations in the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase represent promising therapeutic targets in this disease and have prompted clinical trials of ALK inhibitors. But as with all molecularly targeted therapies, resistance is inevitable and will limit the ultimate utility of this therapeutic strategy. To elucidate the mechanisms of resistance to ALK inhibitors, we have generated isogenic NB cells, expressing the tumorigenic ALKF1174L mutation and amplified MYCN, with acquired resistance to the ALK inhibitor TAE684, through continuous exposure of increasing concentrations of the compound over time. We found that resistance was associated with downregulation of ALK activity, thus ruling out secondary mutations as a mechanism of resistance, and interestingly the other major oncogenic driver in neuroblastoma, MYCN, was downregulated as well. A comparative genome-wide expression analysis revealed global transcriptional downregulation in the resistant cells, as compared with their parental sensitive counterparts, in accordance with the aforementioned MYCN downregulation, as MYCN is known to act as a transcriptional amplifier in MYCN-amplified NB cells. Additionally, these resistant cells exhibited a 10-fold increased sensitivity to the BRD4 inhibitor JQ1, compared to sensitive cells, and MYCN as well as global gene expression were rescued after treatment. These results strongly suggest that resistance to ALK inhibition in ALKF1174L MYCN-amplified NB cells leads to a MYCN-independent enhanced BRD4 dependence, therefore providing a rationale for the use of BET inhibitors to overcome such resistance. Studies are currently underway to characterize the unique epigenetic landscape driving the resistant cells9 survival and therefore identify novel targets that could be taken advantage of in future therapeutic strategies. Citation Format: David Debruyne, Bandana Sharma, Nathanael Gray, Rani George. Resistance to ALK inhibition is associated with enhanced BRD4 dependence in ALK-mutated MYCN-amplified neuroblastoma. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2015 Nov 5-9; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2015;14(12 Suppl 2):Abstract nr LB-C24." @default.
- W2394880936 created "2016-06-24" @default.
- W2394880936 creator A5002000126 @default.
- W2394880936 creator A5015742908 @default.
- W2394880936 creator A5022352605 @default.
- W2394880936 creator A5084564947 @default.
- W2394880936 date "2015-12-01" @default.
- W2394880936 modified "2023-10-02" @default.
- W2394880936 title "Abstract LB-C24: Resistance to ALK inhibition is associated with enhanced BRD4 dependence in ALK-mutated MYCN-amplified neuroblastoma" @default.
- W2394880936 doi "https://doi.org/10.1158/1535-7163.targ-15-lb-c24" @default.
- W2394880936 hasPublicationYear "2015" @default.
- W2394880936 type Work @default.
- W2394880936 sameAs 2394880936 @default.
- W2394880936 citedByCount "0" @default.
- W2394880936 crossrefType "proceedings-article" @default.
- W2394880936 hasAuthorship W2394880936A5002000126 @default.
- W2394880936 hasAuthorship W2394880936A5015742908 @default.
- W2394880936 hasAuthorship W2394880936A5022352605 @default.
- W2394880936 hasAuthorship W2394880936A5084564947 @default.
- W2394880936 hasConcept C104317684 @default.
- W2394880936 hasConcept C117643217 @default.
- W2394880936 hasConcept C119157956 @default.
- W2394880936 hasConcept C126322002 @default.
- W2394880936 hasConcept C127561419 @default.
- W2394880936 hasConcept C153911025 @default.
- W2394880936 hasConcept C2776232967 @default.
- W2394880936 hasConcept C2776715637 @default.
- W2394880936 hasConcept C2778347629 @default.
- W2394880936 hasConcept C2779422266 @default.
- W2394880936 hasConcept C2779634585 @default.
- W2394880936 hasConcept C2779634854 @default.
- W2394880936 hasConcept C2780862049 @default.
- W2394880936 hasConcept C502942594 @default.
- W2394880936 hasConcept C54355233 @default.
- W2394880936 hasConcept C71924100 @default.
- W2394880936 hasConcept C74401373 @default.
- W2394880936 hasConcept C81885089 @default.
- W2394880936 hasConcept C86803240 @default.
- W2394880936 hasConceptScore W2394880936C104317684 @default.
- W2394880936 hasConceptScore W2394880936C117643217 @default.
- W2394880936 hasConceptScore W2394880936C119157956 @default.
- W2394880936 hasConceptScore W2394880936C126322002 @default.
- W2394880936 hasConceptScore W2394880936C127561419 @default.
- W2394880936 hasConceptScore W2394880936C153911025 @default.
- W2394880936 hasConceptScore W2394880936C2776232967 @default.
- W2394880936 hasConceptScore W2394880936C2776715637 @default.
- W2394880936 hasConceptScore W2394880936C2778347629 @default.
- W2394880936 hasConceptScore W2394880936C2779422266 @default.
- W2394880936 hasConceptScore W2394880936C2779634585 @default.
- W2394880936 hasConceptScore W2394880936C2779634854 @default.
- W2394880936 hasConceptScore W2394880936C2780862049 @default.
- W2394880936 hasConceptScore W2394880936C502942594 @default.
- W2394880936 hasConceptScore W2394880936C54355233 @default.
- W2394880936 hasConceptScore W2394880936C71924100 @default.
- W2394880936 hasConceptScore W2394880936C74401373 @default.
- W2394880936 hasConceptScore W2394880936C81885089 @default.
- W2394880936 hasConceptScore W2394880936C86803240 @default.
- W2394880936 hasLocation W23948809361 @default.
- W2394880936 hasOpenAccess W2394880936 @default.
- W2394880936 hasPrimaryLocation W23948809361 @default.
- W2394880936 hasRelatedWork W1545695993 @default.
- W2394880936 hasRelatedWork W2021207337 @default.
- W2394880936 hasRelatedWork W2044464814 @default.
- W2394880936 hasRelatedWork W2280709408 @default.
- W2394880936 hasRelatedWork W2333846122 @default.
- W2394880936 hasRelatedWork W2606636950 @default.
- W2394880936 hasRelatedWork W2792318744 @default.
- W2394880936 hasRelatedWork W2990804030 @default.
- W2394880936 hasRelatedWork W3001681386 @default.
- W2394880936 hasRelatedWork W3017201263 @default.
- W2394880936 hasRelatedWork W3018696360 @default.
- W2394880936 hasRelatedWork W3035918595 @default.
- W2394880936 hasRelatedWork W3080512596 @default.
- W2394880936 hasRelatedWork W3087297916 @default.
- W2394880936 hasRelatedWork W3108222024 @default.
- W2394880936 hasRelatedWork W3110160623 @default.
- W2394880936 hasRelatedWork W3168390353 @default.
- W2394880936 hasRelatedWork W3197537712 @default.
- W2394880936 hasRelatedWork W3204165978 @default.
- W2394880936 hasRelatedWork W611027853 @default.
- W2394880936 isParatext "false" @default.
- W2394880936 isRetracted "false" @default.
- W2394880936 magId "2394880936" @default.
- W2394880936 workType "article" @default.